Negative commercial screening test for paraneoplastic antibodies in a case of opsoclonus

Neurol Neuroimmunol Neuroinflamm. 2017 Feb 3;4(2):e329. doi: 10.1212/NXI.0000000000000329. eCollection 2017 Mar.
No abstract available